MENU
NRC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

NRC stock forecast, quote, news & analysis

NRC Health operates as a humanized healthcare and support organization... Show more

NRC
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
A.I.Advisor
a Summary for NRC with price predictions
Jun 22, 2026

NRC in +9.80% Uptrend, advancing for three consecutive days on June 22, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where NRC advanced for three days, in of 296 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Momentum Indicator moved above the 0 level on June 22, 2026. You may want to consider a long position or call options on NRC as a result. In of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

NRC moved above its 50-day moving average on June 18, 2026 date and that indicates a change from a downward trend to an upward trend.

The Aroon Indicator entered an Uptrend today. In of 187 cases where NRC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for NRC moved out of overbought territory on June 11, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 20 similar instances where the indicator moved out of overbought territory. In of the 20 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Moving Average Convergence Divergence Histogram (MACD) for NRC turned negative on June 11, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NRC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

NRC broke above its upper Bollinger Band on June 10, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: NRC's P/B Ratio (31.153) is slightly higher than the industry average of (7.367). P/E Ratio (49.974) is within average values for comparable stocks, (49.962). NRC's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.152). Dividend Yield (0.029) settles around the average of (0.046) among similar stocks. P/S Ratio (3.111) is also within normal values, averaging (5.631).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NRC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NRC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 99, placing this stock worse than average.

A.I.Advisor
published Dividends

NRC is expected to pay dividends on July 10, 2026

National Research Corp NRC Stock Dividends
A dividend of $0.16 per share will be paid with a record date of July 10, 2026, and an ex-dividend date of June 26, 2026. The last dividend of $0.16 was paid on April 10. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Teladoc Health (NYSE:TDOC).

Industry description

This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.

Market Cap

The average market capitalization across the Services to the Health Industry Industry is 2.04B. The market cap for tickers in the group ranges from 708 to 24.88B. VEEV holds the highest valuation in this group at 24.88B. The lowest valued company is OTRKQ at 708.

High and low price notable news

The average weekly price growth across all stocks in the Services to the Health Industry Industry was -2%. For the same Industry, the average monthly price growth was -1%, and the average quarterly price growth was -13%. SLP experienced the highest price growth at 11%, while MGRX experienced the biggest fall at -19%.

Volume

The average weekly volume growth across all stocks in the Services to the Health Industry Industry was 12%. For the same stocks of the Industry, the average monthly volume growth was 45% and the average quarterly volume growth was 187%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 77
Price Growth Rating: 58
SMR Rating: 88
Profit Risk Rating: 99
Seasonality Score: 26 (-100 ... +100)
View a ticker or compare two or three
NRC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a provider of market research services for the healthcare industry

Industry ServicestotheHealthIndustry

Profile
Details
Industry
Servicestothe Health Industry
Address
5601 South 59th Street
Phone
+1 800 388-4264
Employees
357
Web
https://www.nrchealth.com
NRC in +9.80% Uptrend, advancing for three consecutive days on June 22, 2026